LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 53c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q2 EPS of ($0.53).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• PayPal's CEO Is Planning to Go It Alone and Fix the Payments Giant - WSJ
• GTCR Is Said To Be In Talks To Buy Software Maker SPS Commerce - Bloomberg
• Colgate-Palmolive explores sale of Softsoap, Irish Spring brands